Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parenthetical)

v3.25.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accumulated amortization of deferred leasing costs $ 44,127 $ 44,060
Common shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common shares of beneficial interest, shares issued (in shares) 113,210,642 112,703,460
Common shares of beneficial interest, shares outstanding (in shares) 113,210,642 112,703,460
Investing Receivables    
Investing receivable allowance for credit loss $ 3,575 $ 2,792